Troleandomycin

Contraindicated

Troleandomycin Colchicine Colcrys Explained Increased colchicine exposure and an increased risk of fatal toxicity Details Troleandomycin Dihydroergotamine Injection DHE-45® Injection Increased dihydroergotamine exposure and an increased risk of acute ergot toxicity (ergotism) Details Troleandomycin Dihydroergotamine Nasal Spray Migranal Increased dihydroergotamine exposure and an increased risk of acute ergot toxicity (ergotism) Details Troleandomycin Finerenone Kerendia Increased finerenone exposure and an increased risk of finerenone-related adverse effects Details Troleandomycin Ivabradine Corlanor Increased ivabradine exposure and an increased risk of ivabradine-related adverse effects [like bradycardia and conduction disturb... Details Troleandomycin Lovastatin Altocor® Increased lovastatin exposure and an increased risk of myopathy or rhabdomyolysis Details Troleandomycin Lurasidone Latuda Increased lurasidone exposure Details Troleandomycin Naloxegol Movantik Increased naloxegol exposure and an increased risk of naloxegol-related adverse effects Details

Major

Troleandomycin Acetaminophen And Codeine Capital® & Codeine Explained Increased codeine and morphine exposure Details Troleandomycin Buprenorphine Belbuca Explained Increased buprenorphine exposure and an increased risk of buprenorphine-related adverse events Details Troleandomycin Apixaban Eliquis Explained Increased apixaban exposure Details Troleandomycin Aripiprazole Injection Abilify Increased ARIPiprazole exposure Details Troleandomycin Asciminib Scemblix Increased asciminib exposure and an increased risk of asciminib-related adverse effects Details Troleandomycin Atogepant Qulipta Increased atogepant exposure Details Troleandomycin Avapritinib Ayvakit Increased avapritinib exposure and increased incidence and severity of adverse reactions Details Troleandomycin Atorvastatin Atorvaliq Increased atorvastatin exposure and an increased risk of myopathy or rhabdomyolysis Details Troleandomycin Cariprazine Vraylar Explained Increased exposure to cariprazine and its active metabolite, didesmethylcariprazine Details Troleandomycin Amlodipine Amvaz® Increased amLODIPine exposure and an increased risk of hypotension and edema Details Troleandomycin Beclomethasone Nasal Spray Beconase Increased beclomethasone exposure and an increased risk of beclomethasone-related adverse reactions Details Troleandomycin Beclomethasone Oral Inhalation Beclovent® Increased beclomethasone exposure and an increased risk of beclomethasone-related adverse reactions Details Troleandomycin Bedaquiline Sirturo Increased bedaquiline exposure Details Troleandomycin Bosutinib Bosulif Increased bosutinib exposure Details Troleandomycin Brexpiprazole Rexulti Increased brexpiprazole exposure Details Troleandomycin Budesonide Entocort Increased budesonide exposure Details Troleandomycin Budesonide Nasal Spray Rhinocort Increased budesonide exposure Details Troleandomycin Budesonide Oral Inhalation Pulmicort Increased budesonide exposure Details Troleandomycin Cabozantinib Cabometyx Increased cabozantinib exposure and an increased risk of cabozantinib-related adverse reactions Details Troleandomycin Cabozantinib (Thyroid Cancer) Cabometyx Increased cabozantinib exposure and an increased risk of cabozantinib-related adverse reactions Details Troleandomycin Cyclosporine Injection Atopica Increased cycloSPORINE exposure Details Troleandomycin Cyclosporine Ophthalmic Cequa Increased cycloSPORINE exposure Details Troleandomycin Dasatinib Phyrago Increased dasatinib exposure and an increased risk of dasatinib-related adverse effects Details Troleandomycin Docetaxel Beizray Increased DOCEtaxel exposure Details Troleandomycin Docetaxel Injection Beizray Increased DOCEtaxel exposure Details Troleandomycin Doxorubicin Adriamycin Increased doxorubicin exposure and an increased risk of doxorubicin-related adverse reactions Details Troleandomycin Encorafenib Braftovi Increased encorafenib exposure and an increased risk of encorafenib-related adverse events Details Troleandomycin Entrectinib Rozlytrek Increased entrectinib exposure and an increased frequency or severity of adverse reactions Details Troleandomycin Erdafitinib Balversa Increased erdafitinib exposure Details Troleandomycin Estradiol Delestrogen Increased contraceptive exposure and an increased risk of intrahepatic cholestasis Details Troleandomycin Estradiol Topical Divigel Increased contraceptive exposure and an increased risk of intrahepatic cholestasis Details Troleandomycin Estradiol Transdermal Patch Alora® Increased contraceptive exposure and an increased risk of intrahepatic cholestasis Details